NTCP deficiency in mice protects against obesity and hepatosteatosis
NTCP deficiency in mice protects against obesity and hepatosteatosis
复制标题
DOI:
10.1172/jci.insight.127197
复制
发表时间:
2019-07-25
期刊:
影响因子:
8
通讯作者:
van de Graaf, Stan F. J.
中科院分区:
文献类型:
--
作者:
Donkers, Joanne M.;Kooijman, Sander;van de Graaf, Stan F. J.
Bile acids play a major role in the regulation of lipid and energy metabolism. Here we propose the hepatic bile acid uptake transporter Na+ taurocholate cotransporting polypeptide (NTCP) as a target to prolong postprandial bile acid elevations in plasma. Reducing hepatic clearance of bile acids from plasma by genetic deletion of NTCP moderately increased plasma bile acid levels, reduced diet-induced obesity, attenuated hepatic steatosis, and lowered plasma cholesterol levels. NTCP and G protein-coupled bile acid receptor-double KO (TGR5-double KO) mice were equally protected against diet-induced obesity as NTCP-single KO mice. NTCP-KO mice displayed decreased intestinal fat absorption and a trend toward higher fecal energy output. Furthermore, NTCP deficiency was associated with an increased uncoupled respiration in brown adipose tissue, leading to increased energy expenditure. We conclude that targeting NTCP-mediated bile acid uptake can be a novel approach to treat obesity and obesity-related hepatosteatosis by simultaneously dampening intestinal fat absorption and increasing energy expenditure.